Ziegler Christoph Samuel
SEC insider (Form 3/4/5 filer). CIK 0002123272. Director at Veraxa Biotech AG - Post de-SPAC (VRXA). 1 reported Form 4/5 transaction since Sep 2024; latest on Oct 20, 2026. Located in ZURICH.
Companies Ziegler Christoph Samuel has filed insider reports for
- Veraxa Biotech AG - Post de-SPAC (VRXA): Director
Ziegler Christoph Samuel
CIK: 0002123272
Transaction Breakdown
Open Market Buys (P)1 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VRXA
Veraxa Biotech AG - Post de-SPAC
Director